Pharma Commercialisation Services

Results Healthcare has a long and distinguished history supporting transactions for companies that service the commercialisation of pharmaceuticals and devices by pharma, generic and medical device companies.

Results executed its first transaction in this sector in 1998 with the sale of Adelphi to Omnicom Group. More recently we’ve worked on the sale of iSafety Systems, an Indian pharmacovigilance company which we sold to ProPharma Group, a US company providing drug regulatory services to pharma, generic and biotech companies, in 2021. Between these dates Results Healthcare has been involved in many transactions with a wide range of companies (founder owned or PE-backed) that provide expert services including digital transformation, consulting, analytics, market access, salesforce training, PR and media, to the healthcare industry.

Pharma Commercialisation Services Deals

Aug 2021
a Sovereign Capital Partners-backed company
has acquired
Aug 2021
a Sovereign Capital Partners-backed company
has acquired
Jun 2021
has been acquired by
Apr 2021
has invested in
Mar 2021
has invested in
Jun 2020
has been acquired by
Jun 2020
has been acquired by
Oct 2019
has acquired
Oct 2019
US division
US division, has been acquired by
Aug 2019
has joined
an LDC-backed company

Latest Insights

Insights
17th May 2021

The next chapter: Changing market dynamics in commercialisation and medical communications

The last twelve months have been a time of extraordinary activity in the commercialisation sector – the COVID-19 pandemic saw medcomms groups play a crucial part in keeping pharma companies connected with patients and healthcare professionals, and dealmaking was frenetic on both sides of the Atlantic, for smaller agencies as well as for emerging ‘CCOs’. […]